Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment
Serhat Ozkan,1 Demet Ozbabalik Adapinar,1 Nese Tuncer Elmaci,2 Didem Arslantas31Department of Neurology, Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey; 2Department of Neurology, Marmara University Medical Faculty, Istanbul, Turkey; 3Department of Public Health, Eskisehir Osmangaz...
Guardado en:
Autores principales: | Ozkan S, Adapinar DO, Elmaci NT, Arslantas D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/024722a0fcae40bda106b6cdde6bcb27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs
por: Marco Mauri, et al.
Publicado: (2008) -
Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
por: Samtani MN, et al.
Publicado: (2014) -
Rivastigmine in Chinese patients with subcortical vascular dementia
por: Vincent Mok, et al.
Publicado: (2007) -
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
por: Kandiah N, et al.
Publicado: (2017) -
Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)
por: Harris P, et al.
Publicado: (2015)